Sarcoidosis is a systemic, noncaseating, granulomatous disease affecting young adults
between the ages of 25 and 40 years, most often of Black origin (35.5/100,000 vs 10.9
in the White population). Although the lower respiratory tract is affected in 90%
of cases, ear, nose, and throat locations are very uncommon, with a prevalence varying
between 1% and 6.5%.
1
In addition, ear, nose, and throat manifestations are nonspecific, and may be difficult
to differentiate from other granulomatous diseases such as actinomycosis, aspergillosis,
antineutrophil cytoplasmic antibody-associated vasculitis and tuberculosis, thus,
frequently giving rise to misdiagnosis and delayed treatment.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to The American Journal of MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiology of sarcoidosis.Epidemiol Rev. 1983; 5: 124-156
- Sinonasal sarcoidosis: review and report of fifteen cases.Laryngoscope. 2004; 114: 1960-1963
- Sinonasal sarcoidosis: a new system of classification acting as a guide to diagnosis and treatment.Am J Rhinol Allergy. 2014; 28: 317-322
- Sinonasal manifestations of sarcoidosis: a single institution experience with 38 cases.Int Forum Allergy Rhinol. 2013; 3: 567-572
- The role of endoscopic sinus surgery in chronic sinonasal sarcoidosis.Am J Rhinol. 2001; 15: 249-254
Article info
Publication history
Published online: March 12, 2018
Footnotes
Funding: None.
Conflicts of Interest: None for all authors.
Authorship: All authors had access to the data and a role in writing the manuscript.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
